Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146820 · ClinicalTrials.gov registry record · NA
Picosecond Laser for Ttreatment of Benign Pigmented Lesions
A NA study, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02146820 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 60 participants.
The verdict
NCT02146820, a NA study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Pico laser is effective and safe in the treatment of benign pigmented lesions.
Interventions
- DEVICE GentleMax system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02146820
The ClinicalTrials.gov registry entry for NCT02146820 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GentleMax system is the first listed.
NCT02146820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02146820 about?
NCT02146820 is a clinical study titled "Picosecond Laser for Ttreatment of Benign Pigmented Lesions". The purpose of this study is to determine whether Pico laser is effective and safe in the treatment of benign pigmented lesions.
What is the current status of trial NCT02146820?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-12.
What interventions are being tested in trial NCT02146820?
The interventions under investigation include: GentleMax system (DEVICE).
Who is sponsoring clinical trial NCT02146820?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.